Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

Weight-loss drugs in India may become up to 60% cheaper as semaglutide patents expire on March 20, allowing generic launches by major pharma companies. While prices could drop to ₹3,500–₹4,000 monthly ...

Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March ‌under the brand name Obeda, according to two people ...

Zydus to launch Semaglutide Injection in India, featuring a unique reusable pen for improved diabetes and obesity management.

Zydus plans to launch its diabetes and obesity injection using a reusable adjustable pen device after patent expiry, as more Indian drugmakers enter the market.

Ahmedabad: Zydus Lifesciences Limited said it plans to launch semaglutide injection in India under the brand names Semaglyn, Mashema and Alterme after.